Caricamento...
Genomic biomarkers in prostate cancer
Prostate cancer is the most common non-cutaneous cancer among men in the United States. In the last decade there has been a rapid expansion in the field of biomarker assays for diagnosis, prognosis, and treatment prediction in prostate cancer. The evidence base for these assays is rapidly evolving....
Salvato in:
| Pubblicato in: | Transl Androl Urol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043739/ https://ncbi.nlm.nih.gov/pubmed/30050804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2018.06.02 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|